Evidence map›Paper›PMID 42181312›Full record

ArticleCureus2026

Dexamethasone Iontophoresis for Musculoskeletal Tendinopathies: A Case Series of Three Patients.

Lily Kharlamb, Rachel B Ikhilov, Yevgenia J Gitlin-Nitti

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lily KharlambBiochemistry, City University of New York Graduate Center, New York, USA.
Rachel B IkhilovPharmacy, Long Island University, Brooklyn, USA.
Yevgenia J Gitlin-NittiPhysical Medicine and Rehabilitation, Miami Veterans Affairs Healthcare System, Key West, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Iontophoresis is a non-invasive transdermal drug delivery technique that uses low-voltage electric current to deliver ionized medications into soft tissues. Despite guideline recommendations supporting dexamethasone iontophoresis for tendinopathies, the existing evidence consists primarily of condition-specific randomized controlled trials and single-site retrospective studies, with no published case series illustrating the real-world application of dexamethasone iontophoresis across multiple tendinopathy types within a single report. This case series describes the outcomes of dexamethasone iontophoresis as part of multimodal physical therapy for three distinct tendinopathies. This retrospective case series included three patients treated at a Veterans Affairs physical therapy clinic with dexamethasone sodium phosphate (4 mg/mL) iontophoresis (40 mA-min per session) using the ActivaDose II system. While the small sample size limits generalizability, this series is intended to illustrate the real-world clinical application of dexamethasone iontophoresis across multiple tendinopathy types rather than to establish efficacy. Concurrent interventions included therapeutic exercise, patient education, and orthotic management. Outcomes assessed included pain (0-10 numeric scale), range of motion, grip strength, and Upper Extremity Functional Index (UEFI) scores. Case 1 (de Quervain's tenosynovitis) is a 47-year-old man with persistent, functionally limiting wrist pain who completed seven sessions over 24 days. Pain decreased from 3-4/10 to 1/10, grip strength improved from 60 to 75 lbs (equalizing with the uninvolved side), and UEFI improved by 8 points (exceeding the MCID). Case 2 (fluoroquinolone-associated Achilles tendinopathy) is a 56-year-old woman who completed six sessions over nine weeks. Pain decreased from 8/10 to 2-3/10, and ankle dorsiflexion improved from 7° to 16° (left) and 10° to 20° (right), surpassing the normative threshold of 10°. Case 3 (lateral epicondylitis) is a 62-year-old man with acute-onset symptoms who completed 12 sessions over six weeks. Pain decreased from 8/10 to 2-3/10, grip strength improved from 22 to 110 lbs (exceeding the uninvolved side of 80 lbs), and UEFI improved by 46 points (exceeding the MCID). No adverse effects were reported. Dexamethasone iontophoresis, as part of comprehensive physical therapy, was associated with clinically meaningful improvements in pain, strength, and function across three tendinopathy types. These findings suggest that dexamethasone iontophoresis may serve as a useful non-invasive adjunct in the multimodal management of musculoskeletal tendinopathies, though prospective controlled studies are needed to confirm its independent contribution.

Indexed as

achilles tendinopathyde quervain's tenosynovitisdexamethasoneiontophoresislateral epicondylitisphysical therapytendinopathytransdermal drug delivery

Identifiers

PMID42181312
PMCPMC13190773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.